Label: FLUTICASONE PROPIONATE ALLERGY RELIEF- fluticasone propionate spray, metered
-
NDC Code(s):
72657-159-12,
72657-159-14,
72657-159-24,
72657-159-28, view more72657-159-36, 72657-159-42, 72657-159-48, 72657-159-60, 72657-159-72
- Packager: GLENMARK THERAPEUTICS INC., USA
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated May 5, 2026
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredient (in each spray)
- Purpose
- Uses
-
Warnings
Only for use in the nose. Do not spray into your eyes or mouth.
Do not use
- •
- in children under 4 years of age
- •
- to treat asthma
- •
- if you have an injury or surgery to your nose that is not fully healed
- •
- if you have ever had an allergic reaction to this product or any of the ingredients
Ask a doctor or pharmacist before use if you are taking
- •
- medicine for HIV infection (such as ritonavir)
- •
- a steroid medicine for asthma, allergies or skin rash
- •
- ketoconazole pills (medicine for fungal infection)
When using this product
- •
- the growth rate of some children may be slower
- •
- stinging or sneezing may occur for a few seconds right after use
- •
- do not share this bottle with anyone else as this may spread germs
- •
- remember to tell your doctor about all the medicines you take, including this one
Stop use and ask a doctor if
- •
- you have, or come into contact with someone who has, chicken pox, measles or tuberculosis
- •
- your symptoms do not get better within 7 days of starting use or you get new symptoms such as severe facial pain or thick nasal discharge. You may have something more than allergies, such as an infection.
- •
- you get a constant whistling sound from your nose. This may be a sign of damage inside your nose.
- •
- you get an allergic reaction to this product. Seek medical help right away.
- •
- you get new changes to your vision that develop after starting this product
- •
- you have severe or frequent nosebleeds
-
Directions
- •
- read the Quick Start Guide for how to:
- o
- prime the bottle
- o
- use the spray
- o
- clean the spray nozzle
- •
- shake gently before each use
- •
- use this product only once a day
- •
- do not use more than directed
ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER
- •
- Week 1- use 2 sprays in each nostril once daily
- •
- Week 2 through 6 months- use 1 or 2 sprays in each nostril once daily, as needed to treat your symptoms
- •
- After 6 months of daily use – ask your doctor if you can keep using
CHILDREN 4 TO 11 YEARS OF AGE
- •
- the growth rate of some children may be slower while using this product. Children should use for the shortest amount of time necessary to achieve symptom relief. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year.
- •
- an adult should supervise use
- •
- use 1 spray in each nostril once daily
CHILDREN UNDER 4 YEARS OF AGE
- •
- do not use
- Other information
- Inactive ingredients
- Questions or comments?
-
Generic Section
Fluticasone Propionate Nasal Spray Allergy Relief helps relieve a broad range of uncomfortable symptoms like congestion and itchy eyes.
These symptoms can be triggered by allergens like pollen, mold, dust or pet dander.
Outdoor allergens
Animal allergens
Indoor allergens
Be sure to read the Quick Start Guide and Question & Answer Leaflet inside package
TAMPER-EVIDENT features for your protection. The product is packaged in a sealed carton. Under the cap and nozzle, each bottle has an aluminium seal around bottle neck. Do not use if any of these features are torn or damaged.
-
Principal Display Panel
FLUTICASONE PROPIONATE NASAL SPRAY, USP
50 mcg per spray
ALLERGY SYMPTOM RELIEVER
(Glucocorticoid)*
Non-Drowsy Relief of:
- •
- Nasal congestion
- •
- Itchy, watery eyes
- •
- Itchy nose
- •
- Runny nose
- •
- Sneezing
*Fluticasone propionate is a steroid medicine known as a glucocorticoid.
FULL PRESCRIPTION STRENGTH
24 HOUR ALLERGY RELIEF
120 METERED SPRAYS
0.54 fl oz (15.8 mL)
-
INGREDIENTS AND APPEARANCE
FLUTICASONE PROPIONATE ALLERGY RELIEF
fluticasone propionate spray, meteredProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:72657-159 Route of Administration NASAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FLUTICASONE PROPIONATE (UNII: O2GMZ0LF5W) (FLUTICASONE - UNII:CUT2W21N7U) FLUTICASONE PROPIONATE 50 ug Inactive Ingredients Ingredient Name Strength BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) ANHYDROUS DEXTROSE (UNII: 5SL0G7R0OK) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) PHENYLETHYL ALCOHOL (UNII: ML9LGA7468) POLYSORBATE 80 (UNII: 6OZP39ZG8H) WATER (UNII: 059QF0KO0R) CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72657-159-60 1 in 1 CARTON 03/16/2026 1 60 in 1 BOTTLE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 2 NDC:72657-159-12 1 in 1 CARTON 03/16/2026 2 120 in 1 BOTTLE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 3 NDC:72657-159-24 2 in 1 CARTON 03/16/2026 3 120 in 1 BOTTLE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 4 NDC:72657-159-36 3 in 1 CARTON 03/16/2026 4 120 in 1 BOTTLE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 5 NDC:72657-159-14 1 in 1 CARTON 03/16/2026 5 144 in 1 BOTTLE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 6 NDC:72657-159-28 2 in 1 CARTON 03/16/2026 6 144 in 1 BOTTLE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 7 NDC:72657-159-42 3 in 1 CARTON 03/16/2026 7 144 in 1 BOTTLE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 8 NDC:72657-159-72 1 in 1 CARTON 03/16/2026 8 72 in 1 BOTTLE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 9 NDC:72657-159-48 4 in 1 CARTON 03/16/2026 9 120 in 1 BOTTLE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA218742 03/16/2026 Labeler - GLENMARK THERAPEUTICS INC., USA (969085666) Establishment Name Address ID/FEI Business Operations Glenmark Pharmaceuticals Limited 650565703 MANUFACTURE(72657-159)
